Eleven (23%) of the participants with severe obesity were treated with statins, but their lipid profile, apoA1, apoB and HDL functionality markers did not differ from participants not on statins. This evidence concerns the gene APOA1 and obesity due to melanocortin 4 receptor deficiency.